Microvascular complications= inscreased risk?

The prognostic role of microvascular complications for all-cause death in patients with diabetes hospitalized for coronavirus disease-2019 (COVID-19) has been suggested. However, no detailed analysis of the microvascular burden in these patients is available so far.

We analysed data from the French CORONADO initiative and the United Kingdom ABCD Covid-19 audit, two nationwide multicenter studies, and the AMERICADO, a multicenter study in New York area. We assessed the association between the risk of all-cause death during hospital stay and microvascular complications, in patients with diabetes hospitalized for COVID-19: diabetic retinopathy and/or diabetic kidney disease and/or history of diabetic foot ulcer.

Conclusion: Microvascular burden is associated with an increased risk of death in patients hospitalized for COVID-19.

Published in Diabetes, Obesity and Metabolism, this article is protected by copyright.

All rights reserved.